Abstract
A series of pyrrolopyrazinone-chalcone hybrids(12a–12q) was designed, synthesized and screened for their antitumor activity against SKOV-3, A549 and HeLa cell lines in vitro. Compared with the pyrrolopyrazinone( 10a) and 5-fluorouracil(5-FU), nearly all the tested compounds showed significantly-improved antitumor activities. The most promising compounds 12e and 12k(IC50=0.25 and 0.88 μmol/L) respectively show activities of 123 and 35 times that of compound 10a(IC50=30.74 μmol/L) against HeLa cell line. The result reveals that the presence of chalcone moiety is beneficial to their activity and selectivity.
Similar content being viewed by others
References
Francisco A. V., Lena G., Immunopharm Immunot., 2010, 6, 228
Delphine E. N., Peter M., Thomas L., Chem. Eur. J., 2004, 10, 1141
Kinnel R. B., Gehrken H. P., Swali R., Skoropowski G., Scheuer P. J., J. Org. Chem., 1998, 63, 3281
Thomas L., Delphine J. E. N., Michael Z., Robin B. K., Shayna M., Matthias K., Tetrahedron Lett., 2010, 51, 6353
Charlene K. M., Suzanne M., Patrick G. J., Paul C., Pauline J. E., Mathias M. D., Campbell F. C., Soraya M., Karl J. H., Mohamed E. T., Mol. Cancer Ther., 2008, 7, 548
Umeyama A., Ito S., Yuasa E., Arihara S., Yamada T., J. Nat. Prod., 1998, 61, 1433
Martin G. B., Andrew M. B., Anthony C. W., New J. Chem., 1999, 23, 687
Meng Y., Wang G., Li Y., Hou K., Yuan Y., Zhang L. J., Song H. R., Shi W., Chin. Chem. Lett., 2013, 24, 619
Herencia F., Ferrandiz M. L., Ubeda A., Domínguez J. N., Charris J. E., Lobo G. M., Alcaraz M. J., Bioorg. Med. Chem. Lett., 1998, 8, 1169
Ducki S., Forrest R., Hadfield J. A., Kendall A., Lawrence N. J., McGown A. T., Rennison D., Bioorg. Med. Chem. Lett., 1998, 8, 1051
Tsuchiya H., Sato M., Akagiri M., Takagi N., Tanaka T., Iinuma M., Pharmazie, 1994, 49, 756
Go M. L., Wu X., Liu X. L., Curr. Med. Chem., 2005, 12, 483
Edwards M. L., Stemerick D. M., Sunkara P. S., Michael L. E., David M. S., Prasad S. S., J. Med. Chem., 1990, 33, 1948
Xie L. J., Zhai X., Liu C., Li P., Li Y. X., Guo G. X., Gong P., Arch. Pharm. Chem., 2011, 344, 639
Hsu Y. L., Kuo P. L., Tzeng W. S., Lin C. C., Food Chem. Toxicol., 2006, 44, 704
Nerya O., Musa R., Khatib S., Tamir S., Vaya J., Phytochemistry, 2004, 65, 1389
Sabzevari O., Galati G., Moridani M. Y., Siraki A., O’Brien P. J., Chem. Biol. Interact., 2004, 148, 57
Kim S. H., Lee E., Baek K. H., Kwon H. B., Woo H., Lee E. S., Kwon Y., Na Y., Bioorg. Med. Chem. Lett., 2013, 23, 3320
Rao Y. K., Fang S. H., Tzeng Y. M., Bioorg. Med. Chem., 2004, 12, 2679
Xie L. J., Zhai X., Ren L. X., Meng H. Y., Liu C., Zhu W. F., Zhao Y. F., Chem. Pharm. Bull., 2011, 59, 984
Lv Z. L., Gao Y., Li J., Huang T.K., He S. J., Zou Y., Chem. J. Chinese Universities, 2013, 34(11), 2531
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Program for Liaoning Innovative Research Team in University, China(No.2007T177).
Rights and permissions
About this article
Cite this article
Meng, Y., Zhang, H., Liu, Z. et al. Design, synthesis and antitumor activity of pyrrolopyrazinone-chalcone hybrids. Chem. Res. Chin. Univ. 30, 624–631 (2014). https://doi.org/10.1007/s40242-014-3542-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-3542-z